In addition, we confirmed the results in a microarray assay of RCC samples, in which JMJD6 was significantly elevated in RCC samples compared with paired normal tissue samples, as determined by immunohistochemistry (IHC) (N = 280, P < 0.001, Figures 2E and 2F). Here, JMJD6 is linked to renal cell carcinoma.